Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

por Södergren, Anna, Karp, Kjell, Bengtsson, Christine, Möller, Bozena, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Publicado 2015

Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis

por Södergren, Anna, Karp, Kjell, Bengtsson, Christine, Möller, Bozena, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Publicado 2019

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

por Innala, Lena, Berglin, Ewa, Möller, Bozena, Ljung, Lotta, Smedby, Torgny, Södergren, Anna, Magnusson, Staffan, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Publicado 2014

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters

por Innala, Lena, Sjöberg, Clara, Möller, Bozena, Ljung, Lotta, Smedby, Torgny, Södergren, Anna, Magnusson, Staffan, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Publicado 2016

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

por Innala, Lena, Möller, Bozena, Ljung, Lotta, Magnusson, Staffan, Smedby, Torgny, Södergren, Anna, Öhman, Marie-Louise, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Publicado 2011